PLPeter I. Lelkes

Peter I. Lelkes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Peter I. Lelkes has a total of 86 co-authors. Here are the top co-authors by number of shared publications:

  • Cezary Marcinkiewicz

    College of Engineering, Temple Univ, Philadelphia, PA

    3 shared publications
  • Philip Lazarovici

    School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel

    3 shared publications
  • Yen Wei

    Integrated Laboratory for Cellular Tissue Engineering and Regenerative Medicine, School of Biomedical Engineering, Science and Health Systems and Department of Chemistry, Drexel University, Philadelphia, Pennsylvania, 19104, United States, and Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Science, Changchun, 130022, P.R. China

    3 shared publications
  • Anat Perets

    School of Biomedical Engineering, Science and Health Systems; Drexel University; Philadelphia PA USA

    2 shared publications
  • Donald M. Simons

    School of Biomedical Engineering, Sciences, and Health Systems, Drexel University, Philadelphia, Pennsylvania

    2 shared publications
  • Mark J. Mondrinos

    School of Biomedical Engineering, Sciences, and Health Systems, Drexel University, Philadelphia, Pennsylvania

    2 shared publications

Latest Publications

  • Abstract WP56: Imaging Intra-Carotid Thrombosis Using Near InfraRed Fluorescent-NanoDiamond Particles Bio-engineered With the Disintegrin Bitistatin

    by Frank C Barone, Jonathan A Gerstenhaber, Cezary Marcinkiewicz, Jie Li, Peter I Lelkes, Mark Sternberg, Giora Z Feuerstein

    Background: Thromboembolism is a major cause of events in carotid artery (CA) disease and predisposes the dissemination of clots to upstream ischemic strokes. Although diagnostic methods are available to define thromboembolic strokes (CT, MRI, etc.), there is no technology to provide ambulatory assessment to ‘content image’ thrombi within the CA bifurcation free of the hospital setting. To address this unmet medical need we bioengineered the joining of the disintegrin bitistatin (Bit) to fluorescent NanoDiamond Particles (F-NDP) in order to bind to and non-invasively image vascular clots. F-NDP-Bit preferentially binds to the human platelet fibrinogen receptor (GPIIB/IIIA). F-NDP-Bit was systematically evaluated for NIR emission capacity in various tissues and demonstrated penetration of NIR fluorescence across distances similar to the distance from the human skin surface to the CA bifurcation. Methods: In vitro studies were conducted to evaluate binding of F-NDP-Bit to purified human GPIIB/IIIA. Also, the ability of the F-NDP-Bit to bind to vascular clots In Vivo was investigated in rat FeCl3-induced internal CA coagulation. Results: Using the specific GPIIB/IIIA antagonist lotrafiban, In Vitro specific and concentration-related F-NDP-Bit binding was demonstrated. In Vivo , intravenous administration of F-NDP-Bit during the evolution of FeCl3-induced internal CA thrombosis resulted in the dose-related clot accumulation of F-NDP-Bit that was cross-validated by three independent methods (all measures were significant as described; p < 0.05): ( 1 ) In Situ whole rat imaging via In Vivo Imaging System (IVIS: using Ex 54 nm; Em 695-770 nm); ( 2 ) Ex Vivo whole vessel/clot imaging (Scanning Confocal Microscopy), and ( 3 ) Extract, isolate and quantitate F-NDP-Bit following internal CA clot dissolution (12N HNO3) and direct counting (hemocytometer). Conclusions: These data indicate that F-NDP-Bit might address the need for fast, safe and highly affordable ambulatory imaging of vascular clot burden. Functionalization of F-NDP with selective ligands that can be pathognomonic for many disease situations also could facilitate risk assessment, earlier intervention and preventative medicine.

  • Alimentary ‘green’ proteins as electrospun scaffolds for skin regenerative engineering

    by Leko Lin, Anat Perets, Yah-El Har-El, Devika Varma, Mengyan Li, Philip Lazarovici, Dara L. Woerdeman, Peter I. Lelkes

    As a potential alternative to currently available skin substitutes and wound dressings, we explored the use of bioactive scaffolds made of plant-derived proteins. We hypothesized that ‘green’ materials, derived from renewable and biodegradable natural sources, may confer bioactive properties to enhance wound healing and tissue regeneration. We optimized and characterized fibrous scaffolds electrospun from soy protein isolate (SPI) with addition of 0.05% poly(ethylene oxide) (PEO) dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol, and from corn zein dissolved in glacial acetic acid. Fibrous mats electrospun from either of these plant proteins remained intact without further cross-linking, possessing a skin-like pliability. Soy-derived scaffolds supported the adhesion and proliferation of cultured primary human dermal fibroblasts. Using targeted PCR arrays and qPCR validation, we found similar gene expression profiles of fibroblasts cultured for 2 and 24 h on SPI substrates and on collagen type I at both time points. On both substrates there was a pronounced time-dependent upregulation of several genes related to ECM deposition remodelling, including MMP-10, MMP-1, collagen VII, integrin-α2 and laminin-β3, indicating that both plant- and animal-derived materials induce similar responses from the cells after initial adhesion, degrading substrate proteins and depositing extracellular matrix in a ‘normal’ remodelling process. These results suggest that ‘green’ proteins, such as soy and zein, are promising as a platform for organotypic skin equivalent culture, as well as implantable scaffolds for skin regeneration. Future studies will determine specific mechanisms of their interaction with skin cells and their efficacy in wound-healing applications. Copyright © 2012 John Wiley & Sons, Ltd.


  • Nerve Growth Factor and Human Umbilical Cord Blood-Derived Cells Confer Neurovascular Protection in Ischemia

    by Philip Lazarovici, Hadar Arien-Zakay, Shimon Lecht, Hanan Galski, Esther Shohami, Arnon Nagler, Cezary Marcinkiewicz, Peter I. Lelkes

    Human umbilical cord blood (HUCB), a valuable source for cell therapy of hematologic diseases, was recently found to confer neuroprotection in animal models of brain injury. To explore the neuroprotective properties of HUCB in an ischemic environment, we studied a unique sub-population of collagen-adherent cells. In the presence of nerve growth factor (NGF) and interferon-gamma, these cells differentiate in vitro into a neuronal phenotype (termed HUCBNP). Using a closed-head injury brain trauma model, we recently demonstrated neuroprotective effects of HUCB upon their local injection into the brain. Our in-vitro studies indicated that upon co-culture with ischemia exposed PC12 cells, HUCBNP conferred about 30% neuroprotection, as assessed by decreased lactate dehydrogenase (LDH) release and inhibition of caspase-3 activity. HUCBNP decreased by 95% the level of free radicals in the insulted-PC12 cells, which was in correlation with the appearance of antioxidants and NGF in the medium. HUCBNP-induced neuroprotection also correlated with changes in NGF mRNA expression levels, a process which was blocked by K252a, an antagonist of the NGF-neurotrophin receptor TrkA. To further extend the possible contribution of NGF-mediated protective role, we investigated its neuroprotective mechanisms using PC12 cells and brain capillary endothelial cells exposed to ischemic insult. Pretreatment of the cultures with NGF conferred neuroprotection in a dose- and time-dependent fashion. Time course experiments indicated marked activation of mitogen activated protein kinasas (MAPKs) during the ischemic insult, while treatment of the cultures with NGF inhibited them to different degrees. It appears that both neuronal and endothelial compartments may be protected by NGF under ischemic conditions. Therefore, in future neuroprotection studies, we propose to address additional components of the neurovascular unit such as astrocytes and pericytes in mono-, co- and multi-culture setups. In conclusion, our findings indicate that HUCBNP-induced neuroprotection involves antioxidant(s) and NGF, which by paracrine and/or autocrine route, affects all components of the neurovascular unit.

  • Open Access

    Fibronectin-mediated upregulation of α5β1 integrin and cell adhesion during differentiation of mouse embryonic stem cells

    by Pimchanok Pimton, Saheli Sarkar, Nidhi Sheth, Anat Perets, Cezary Marcinkiewicz, Philip Lazarovici, Peter I. Lelkes

    Embryonic stem (ES) cells have a broad potential application in regenerative medicine and can be differentiated into cells of all three germ layers. Adhesion of ES cells to extracellular matrix (EC...


  • Thermosensitive/Photocrosslinkable Hydrogel for Soft Tissue Scaffold Printing

    by Chris G. Geisler, Ho-Lung Li, Qingwei Zhang, Jack G. Zhou, David M. Wootton, Peter I. Lelkes

    A new type of hydrogel for solid free-form fabrication (SFF) and rapid prototyping (RP) that obtains the qualities of a photocrosslinkable and thermosensitive hydrogel would benefit the tissue engineering field. For a material to best suit SFF and RP, it must: 1) be a low-viscous solution before being printed, 2) involve easily joined on-substrate mixing to form a homogenous gel, 3) have a short solution to gel transition time, 4) be a mechanically strong gel, and 5) have an irreversible gelation processes. A biodegradable, biocompatable thermosensitive triblock copolymer, poly(ethylene glycol-b-(DLlactic acid-co-glycolic acid)-b-ethylene glycol) (PEG-PLGA-PEG), crosslinked with photocrosslinkable Irgacure 2959 allows for quick irreversible transition from solution to gel with a post-processing step utilizing UV light. A material that gels instantaneously from a non-viscous solution to a 3-dimensional building gel could be used in multiple different types of SFF methods already developed. Since the material is also biocompatible, it can be used to replicate many different types of tissues. In this paper, the mechanism of gelation is proposed and the material relationship to the initial viscosity is investigated.

  • Co-Electrospun Blends of PLGA, Gelatin, and Elastin as Potential Nonthrombogenic Scaffolds for Vascular Tissue Engineering

    by Jingjia Han, Philip Lazarovici, Colin Pomerantz, Xuesi Chen, Yen Wei, Peter I. Lelkes

    In search for novel biomimetic scaffolds for application in vascular tissue engineering, we evaluated a series of fibrous scaffolds prepared by coelectrospinning tertiary blends of poly(lactide-co-glycolide) (PLGA), gelatin, and elastin (PGE). By systematically varying the ratios of PLGA and gelatin, we could fine-tune fiber size and swelling upon hydration as well as the mechanical properties of the scaffolds. Of all PGE blends tested, PGE321 (PLGA, gelatin, elastin v/v/v ratios of 3:2:1) produced the smallest fiber size (317 ± 46 nm, 446 ± 69 nm once hydrated) and exhibited the highest Young’s modulus (770 ± 131 kPa) and tensile strength (130 ± 7 kPa). All PGE scaffolds supported the attachment and metabolization of human endothelial cells (ECs) and bovine aortic smooth muscle cells (SMCs) with some variances in EC morphology and cytoskeletal spreading observed at 48 h postseeding, whereas no morphologic differences were observed at confluence (day 8). The rate of metabolization of ECs, but not of SMCs, was lower than that on tissue culture plastic and depended on the specific PGE composition. Importantly, PGE scaffolds were capable of guiding the organotypic distribution of ECs and SMCs on and within the scaffolds, respectively. Moreover, the EC monolayer generated on the PGE scaffold surface was nonthrombogenic and functional, as assessed by the basal and cytokine-inducible levels of mRNA expression and amidolytic activity of tissue factor, a key player in the extrinsic clotting cascade. Taken together, our data indicate the potential application of PGE scaffolds in vascular tissue engineering.


  • Intact T cell receptor signaling by CD4+ T cells cultured in the rotating wall‐vessel bioreactor

    by D.M. Simons, E.M. Gardner, P.I. Lelkes

    T lymphocytes fail to proliferate or secrete cytokines in response to T cell receptor (TCR) agonists during culture in spaceflight or ground-based microgravity analogs such as rotating wall-vessel (RWV) bioreactors. In RWVs, these responses can be rescued by co-stimulation with sub-mitogenic doses of the diacyl glycerol (DAG) mimetic phorbol myristate acetate. Based on this result we hypothesized that TCR activation is abrogated in the RWV due to impaired DAG signaling downstream of the TCR. To test this hypothesis we compared TCR-induced signal transduction by primary, human, CD4+ T cells in RWV, and static culture. Surprisingly, we found little evidence of impaired DAG signaling in the RWV. Upstream of DAG, the tyrosine phosphorylation of several key components of the TCR-proximal signal was not affected by culture in the RWV. Similarly, the phosphorylation and compartmentalization of ERK and the degradation of IκB were unchanged by culture in the RWV indicating that RAS- and PKC-mediated signaling downstream of DAG are also unaffected by simulated microgravity. We conclude from these data that TCR signaling through DAG remains intact during culture in the RWV, and that the loss of functional T cell activation in this venue derives from the affect of simulated microgravity on cellular processes that are independent of the canonical TCR pathway. J. Cell. Biochem. 109: 1201–1209, 2010.


  • Efficient Derivation of Alveolar Type II Cells from Embryonic Stem Cells for In Vivo Application

    by Blair Roszell, Mark J. Mondrinos, Ariel Seaton, Donald M. Simons, Sirma H. Koutzaki, Guo-Hua Fong, Peter I. Lelkes, Christine M. Finck

    In the present study, mouse embryonic stem cells (ESCs) were differentiated into alveolar epithelial type II (AEII) cells for endotracheal injection. These enriched lung-like populations expressed lung epithelial markers SP-A, SP-B, SP-C, and CC10. First we show that rapid differentiation of ESCs requires a dissociated seeding method instead of an embryoid body culture method. We then investigated a two-step differentiation of ESCs into definitive endoderm by activin or A549-conditioned medium as a precursor to lung epithelial cells. When conditioned medium from A549 cells was used to derive endoderm, yield was increased above that of activin alone. Further studies showed that Wnt3a may be one of the secreted factors produced by A549 cells and promotes definitive endoderm differentiation, in part, through suppression of primitive endoderm. Activin and Wnt3a together at appropriate doses with dissociated cell seeding promoted greater endoderm yield than activin alone. Next, fibroblast growth factor 2 was shown to induce a dose-dependent expression of SPC, and these cells contained lamellar bodies characteristic of mature AEII cells from ESC-derived endoderm. Finally, ES-derived lung cells were endotracheally injected into preterm mice with evidence of AEII distribution within the lung parenchyma. This study concludes that a recapitulation of development may enhance derivation of an enriched population of lung-like cells for use in cell-based therapy.